{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T13:57:00Z","timestamp":1776434220360,"version":"3.51.2"},"reference-count":28,"publisher":"Baskent University","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp Clin Transplant"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.6002\/ect.2025.0214","type":"journal-issue","created":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T12:49:32Z","timestamp":1776430172000},"source":"Crossref","is-referenced-by-count":0,"title":[],"prefix":"10.6002","volume":"24","member":"4021","reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"1. Tonelli M, Wiebe N, Knoll G, et al. Systematic review: kidney transplantation compared with dialysis in clinically relevant outcomes. Am J Transplant. 2011;11(10):2093-2109. doi:10.1111\/j.1600-6143.2011.03686.x","DOI":"10.1111\/j.1600-6143.2011.03686.x"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"2. Sawinski D, Goral S. BK virus infection: an update on diagnosis and treatment. Nephrol Dial Transplant. 2015;30(2):209-217. doi:10.1093\/ndt\/gfu023","DOI":"10.1093\/ndt\/gfu023"},{"key":"ref2","unstructured":"3. van Aalderen MC, Heutinck KM, Huisman C, ten Berge IJ. BK virus infection in transplant recipients: clinical manifestations, treatment options and the immune response. Neth J Med. 2012;70(4):172-183."},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"4. Johnston O, Jaswal D, Gill JS, Doucette S, Fergusson DA, Knoll GA. Treatment of polyomavirus infection in kidney transplant recipients: a systematic review. Transplantation. 2010;89(9):1057-1070. doi:10.1097\/TP.0b013e3181d0e15e","DOI":"10.1097\/TP.0b013e3181d0e15e"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"5. Hirsch HH, Brennan DC, Drachenberg CB, et al. Polyomavirus-associated nephropathy in renal transplantation: interdisciplinary analyses and recommendations. Transplantation. 2005;79(10):1277-1286. doi:10.1097\/01.tp.0000156165.83160.09","DOI":"10.1097\/01.TP.0000156165.83160.09"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"6. Chadban SJ, Ahn C, Axelrod DA, et al. KDIGO clinical practice guideline on the evaluation and management of candidates for kidney transplantation. Transplantation. 2020;104(4S1 Suppl 1):S11-S103. doi:10.1097\/TP.0000000000003136","DOI":"10.1097\/TP.0000000000003136"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"7. Kant S, Dasgupta A, Bagnasco S, Brennan DC. BK virus nephropathy in kidney transplantation: a state-of-the-art review. Viruses. 2022;14(8)doi:10.3390\/v14081616","DOI":"10.3390\/v14081616"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"8. Nickeleit V, Singh HK, Randhawa P, et al. The Banff Working Group Classification of definitive polyomavirus nephropathy: morphologic definitions and clinical correlations. J Am Soc Nephrol. 2018;29(2):680-693. doi:10.1681\/ASN.2017050477","DOI":"10.1681\/ASN.2017050477"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"9. Roufosse C, Simmonds N, Clahsen-van Groningen M, et al. A 2018 Reference Guide to the Banff Classification of renal allograft pathology. Transplantation. 2018;102(11):1795-1814. doi:10.1097\/TP.0000000000002366","DOI":"10.1097\/TP.0000000000002366"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"10. Sood P, Senanayake S, Sujeet K, et al. Management and outcome of BK viremia in renal transplant recipients: a prospective single-center study. Transplantation. 2012;94(8):814-821. doi:10.1097\/TP.0b013e31826690c6","DOI":"10.1097\/TP.0b013e31826690c6"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"11. Shen CL, Wu BS, Lien TJ, Yang AH, Yang CY. BK polyomavirus nephropathy in kidney transplantation: balancing rejection and infection. Viruses. 2021;13(3)doi:10.3390\/v13030487","DOI":"10.3390\/v13030487"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"12. Lamarche C, Orio J, Collette S, et al. BK polyomavirus and the transplanted kidney: immunopathology and therapeutic approaches. Transplantation. 2016;100(11):2276-2287. doi:10.1097\/TP.0000000000001333","DOI":"10.1097\/TP.0000000000001333"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"13. Masutani K, Shapiro R, Basu A, Tan H, Wijkstrom M, Randhawa P. The Banff 2009 Working Proposal for polyomavirus nephropathy: a critical evaluation of its utility as a determinant of clinical outcome. Am J Transplant. 2012;12(4):907-918. doi:10.1111\/j.1600-6143.2012.03993.x","DOI":"10.1111\/j.1600-6143.2012.03993.x"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"14. Vasudev B, Hariharan S, Hussain SA, Zhu YR, Bresnahan BA, Cohen EP. BK virus nephritis: risk factors, timing, and outcome in renal transplant recipients. Kidney Int. 2005;68(4):1834-1839. doi:10.1111\/j.1523-1755.2005.00602.x","DOI":"10.1111\/j.1523-1755.2005.00602.x"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"15. Kotton CN, Kamar N, Wojciechowski D, et al. The Second International Consensus Guidelines on the Management of BK Polyomavirus in Kidney Transplantation. Transplantation. 2024;108(9):1834-1866. doi:10.1097\/TP.0000000000004976","DOI":"10.1097\/TP.0000000000004976"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"16. Hirsch HH, Randhawa P; AST Infectious Diseases Community of Practice. BK polyomavirus in solid organ transplantation. Am J Transplant. 2013;13 Suppl 4:179-188. doi:10.1111\/ajt.12110","DOI":"10.1111\/ajt.12110"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"17. Zaman RA, Ettenger RB, Cheam H, Malekzadeh MH, Tsai EW. A novel treatment regimen for BK viremia. Transplantation. 2014;97(11):1166-1171. doi:10.1097\/01.TP.0000441825.72639.4f","DOI":"10.1097\/01.TP.0000441825.72639.4f"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"18. Nickeleit V, Singh HK, Dadhania D, et al. The 2018 Banff Working Group classification of definitive polyomavirus nephropathy: a multicenter validation study in the modern era. Am J Transplant. 2021;21(2):669-680. doi:10.1111\/ajt.16189","DOI":"10.1111\/ajt.16189"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"19. Wang M, Zhou Q, Wang H, Chen Y, Chen J. An application of the 2018 Banff Classification for BK polyomavirus-associated nephropathy in renal transplantation. Transpl Infect Dis. 2021;23(3):e13557. doi:10.1111\/tid.13557","DOI":"10.1111\/tid.13557"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"20. Bouatou Y, Nguyen TQ, Roelofs J, et al. A Multicenter Application of the 2018 Banff Classification for BK polyomavirus-associated nephropathy in renal transplantation. Transplantation. 2019;103(12):2692-2700. doi:10.1097\/TP.0000000000002712","DOI":"10.1097\/TP.0000000000002712"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"21. Masutani K. Current problems in screening, diagnosis and treatment of polyomavirus BK nephropathy. Nephrology (Carlton). 2014;19 Suppl 3:11-16. doi:10.1111\/nep.12254","DOI":"10.1111\/nep.12254"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"22. Hirsch HH, Randhawa PS; AST Infectious Diseases Community of Practice. BK polyomavirus in solid organ transplantation-Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant. 2019;33(9):e13528. doi:10.1111\/ctr.13528","DOI":"10.1111\/ctr.13528"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"23. Saad ER, Bresnahan BA, Cohen EP, et al. Successful treatment of BK viremia using reduction in immunosuppression without antiviral therapy. Transplantation. 2008;85(6):850-854. doi:10.1097\/TP.0b013e318166cba8","DOI":"10.1097\/TP.0b013e318166cba8"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"24. Omic H, Klager JP, Herkner H, et al. Clinical relevance of absolute BK polyoma viral load kinetics in patients with biopsy proven BK polyomavirus associated nephropathy. Front Med (Lausanne). 2021;8:791087. doi:10.3389\/fmed.2021.791087","DOI":"10.3389\/fmed.2021.791087"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"25. Kojc N, Ales Rigler A, Mlinsek G, Kovac D, Ferluga D, Arnol M. Outcome of polyomavirus nephropathy in renal transplant patients: a single-center experience. Clin Nephrol. 2017;88(13):109-114. doi:10.5414\/CNP88FX24","DOI":"10.5414\/CNP88FX24"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"26. Almeras C, Foulongne V, Garrigue V, et al. Does reduction in immunosuppression in viremic patients prevent BK virus nephropathy in de novo renal transplant recipients? A prospective study. Transplantation. 2008;85(8):1099-1104. doi:10.1097\/TP.0b013e31816a33d4","DOI":"10.1097\/TP.0b013e31816a33d4"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"27. Iwasaki S, Takahashi K, Katano H, et al. BK polyomavirus-associated urothelial carcinoma of the bladder with a background of BK polyomavirus nephropathy in a kidney transplant recipient. Nephron. 2023;147 Suppl 1:53-60. doi:10.1159\/000531822","DOI":"10.1159\/000531822"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"28. Al-Talib M, Welberry-Smith M, Macdonald A, Griffin S. BK Polyomavirus-associated nephropathy - diagnostic and treatment standard. Nephrol Dial Transplant. 2025;40(4):651-661. doi:10.1093\/ndt\/gfaf002","DOI":"10.1093\/ndt\/gfaf002"}],"container-title":["Experimental and Clinical Transplantation"],"original-title":[],"deposited":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T13:06:23Z","timestamp":1776431183000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ectrx.org\/detail\/archive\/2026\/24\/3\/0\/227\/0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"URL":"https:\/\/doi.org\/10.6002\/ect.2025.0214","relation":{},"ISSN":["1304-0855","2146-8427"],"issn-type":[{"value":"1304-0855","type":"print"},{"value":"2146-8427","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3]]}}}